Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

ReShape Lifesciences Inc. (OBLN)

Cash Flow Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsJun-30-23Mar-31-23Sep-30-22Jun-30-22Mar-31-22Dec-31-21Sep-30-21Jun-30-21
   10-Q10-Q10-Q10-Q10-Q10-K10-Q10-Q
Net income    -64.8-70.7-65.2-61.9-35.0-22.5
Depreciation and amortization   [+]  2.22.22.12.01.81.7
Asset impairment charges    14.00.30.2 0.20.0
Stock-based compensation    4.214.513.412.810.80.3
Deferred taxes    -0.4  -0.1  
Change in working capital   [+]  0.6-2.8-3.1-2.5-2.62.1
Other operating activities    21.831.531.834.311.311.6
Cash from operations    -22.5-25.0-20.8-15.4-13.7-6.9
   
Capital expenditures   [+]  -0.1-0.2-0.2-0.4-0.4-0.5
Acquisitions       22.4 23.4
Other cash from investing         -20.1
Cash from investing    -3.1-3.12.01.92.82.7
   
Option exercises        0.40.2
Financing costs        -3.2 
Other cash from financing    2.5-3.6  35.643.1
Cash from financing    2.5-0.532.333.338.442.9
   
Free cash flow    -22.6-25.2-21.0-15.7-14.2-7.4
        Per share (diluted)    ($2.53)($3.34)($2.45)($1.66)($1.92)($1.81)
   
Cash paid for interest         0.3
Cash paid for income taxes       0.10.0 

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy